Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Adherence to Antiretroviral Therapy and Virologic Failure

    Access Status
    Open access via publisher
    Authors
    Bezabhe, W.
    Stafford, Leanne
    Bereznicki, L.
    Peterson, G.
    Date
    2016
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Bezabhe, W. and Stafford, L. and Bereznicki, L. and Peterson, G. 2016. Adherence to Antiretroviral Therapy and Virologic Failure. Medicine. 95 (15).
    Source Title
    Medicine
    DOI
    10.1097/MD.0000000000003361
    ISSN
    0025-7974
    School
    School of Pharmacy
    URI
    http://hdl.handle.net/20.500.11937/58515
    Collection
    • Curtin Research Publications
    Abstract

    © 2016 Wolters Kluwer Health, Inc. All rights reserved.The often cited need to achieve =95% (nearly perfect) adherence to antiretroviral therapy (ART) for successful virologic outcomes in HIV may present a barrier to initiation of therapy in the early stages of HIV. This meta-analysis synthesized 43 studies (27,905 participants) performed across >26 countries, to determine the relationship between cut-off point for optimal adherence to ART and virologic outcomes. Meta-analysis was performed using a random-effect model to calculate pooled odds ratios with corresponding 95% confidence intervals. The mean rate of patients reporting optimal adherence was 63.4%. Compared with suboptimal adherence, optimal adherence was associated with a lower risk of virologic failure (0.34; 95% CI: 0.26-0.44). There were no significant differences in the pooled odds ratios among different optimal adherence thresholds (=98-100%, =95%, =80-90%). Study design (randomized controlled trial vs observational study) (regression coefficient 0.74, 95% CI: 0.04-1.43, P<0.05) and study region (developing vs developed countries; regression coefficient 0.56, 95% CI: 0.01-1.12, P<0.05) remained as independent predictors of between-study heterogeneity, with more patients with optimal adherence from developing countries or randomized controlled trials experiencing virologic failure. The threshold for optimal adherence to achieve better virologic outcomes appears to be wider than the commonly used cut-off point (=95% adherence). The cut-off point for optimal adherence could be redefined to a slightly lower level to encourage the prescribing ART at an early stage of HIV infection.

    Related items

    Showing items related by title, author, creator and subject.

    • Social determinants of health and diabetes self-care management in South Africa
      Hellebo, A.; Kengne, A.P.; Obse, A.; Levitt, N.; Myers, Bronwyn ; Cleary, S.; Alaba, O. (2024)
      Objective: Diabetes is an incapacitating condition affecting millions of people in South Africa. Maintaining optimal glycaemic control is crucial in preventing diabetes complications, highlighting the importance of diabetes ...
    • Antiretroviral adherence and treatment outcomes among adult Ethiopian patients
      Bezabhe, W.; Stafford, Leanne; Bereznicki, L.; Gee, P.; Peterson, G. (2016)
      © 2016 Informa UK Limited, trading as Taylor & Francis Group.Developing appropriate strategies to sustain optimal medication adherence among the increasing number of HIV-positive patients taking antiretroviral therapy ...
    • Medication adherence self-report instruments: Implications for Practice and Research
      Rolley, John; Davidson, Patricia; Dennison, C.; Ong, A.; Everett, B.; Salamonson, Y. (2008)
      After an acute cardiac event, adhering to recommendations for pharmacologic therapy is important in achieving optimal health outcomes. Considering the impressive evidence base for cardiovascular pharmacotherapy, strategies ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.